[Multiple sclerosis].
Ochi
H
H
Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University.
Kira
J
J
D000818:Animals; D015551:Autoimmunity; D003937:Diagnosis, Differential; D000068717:Glatiramer Acetate; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D016899:Interferon-beta / Q000627:therapeutic use; D008775:Methylprednisolone / Q000008:administration & dosage; D009103:Multiple Sclerosis / Q000209:etiology / Q000628:therapy; D009185:Myelin Proteins / Q000276:immunology; D010455:Peptides / Q000627:therapeutic use; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D013601:T-Lymphocytes / Q000276:immunology
D016756:Immunoglobulins, Intravenous; D009185:Myelin Proteins; D010455:Peptides; D000068717:Glatiramer Acetate; D016899:Interferon-beta; D011239:Prednisolone; D008775:Methylprednisolone